MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
95.04%
Quick Ratio
95.04%
Cash Ratio
69.97%
Debt to Asset Ratio
104.51%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Operating lease right-of-use ass...
    • Other assets
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Estimate for accrued legal conti...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
8,068,357
8,149,015
5,882,498
18,441,079
Short-term investments
1,995,784
8,959,614
19,854,723
16,871,229
Prepaid expenses
415,164
1,223,534
504,890
3,712,311
Other current assets
479,582
234,806
852,036
900,175
Total current assets
10,958,887
18,566,969
27,094,147
39,924,794
Property and equipment, net
32,939
756,077
898,930
1,033,965
Operating lease right-of-use asset
33,660
57,781
266,646
311,620
Other assets
8,309
35,909
53,910
53,910
Total assets
11,033,795
19,416,736
28,313,633
41,324,289
Accounts payable
4,278,419
3,936,948
2,033,431
2,825,005
Accrued payroll liabilities
690,566
234,392
1,269,474
920,774
Other current liabilities
966,121
3,347,515
2,643,840
2,366,123
Estimate for accrued legal contingencies and related expenses
5,417,250
2,574,759
2,069,067
2,054,357
Insurance premium loan payable
143,050
250,338
-
-
Operating lease liability, current portion
35,696
60,980
189,647
201,638
Total current liabilities
11,531,102
10,404,932
8,205,459
8,367,897
Operating lease liability, net of current portion
0
0
83,999
120,207
Total liabilities
11,531,102
10,404,932
8,289,458
8,488,104
Common stock, 0.001 par value 300,000,000 and 100,000,000 shares authorized at june30, 2026 and december31, 2025 35,143,722 and 33,378,139 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
35,144
35,128
33,379
30,989
Additional paid-in-capital
209,637,990
208,360,523
206,865,282
205,237,719
Accumulated deficit
-210,170,441
-199,383,847
-186,874,486
-172,432,523
Total stockholders equity (deficit)
-497,307
9,011,804
20,024,175
32,836,185
Total liabilities and stockholders equity (deficit)
11,033,795
19,416,736
28,313,633
41,324,289
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$8,068,357 (-66.15%↓ Y/Y)Short-term investments$1,995,784 (-91.94%↓ Y/Y)Other current assets$479,582 (-34.61%↓ Y/Y)Prepaid expenses$415,164 (-67.15%↓ Y/Y)Total current assets$10,958,887 (-78.33%↓ Y/Y)Operating leaseright-of-use asset$33,660 (-90.53%↓ Y/Y)Property and equipment,net$32,939 (-97.18%↓ Y/Y)Other assets$8,309 (-84.59%↓ Y/Y)Total assets$11,033,795 (-78.85%↓ Y/Y)Accumulated deficit-$210,170,441 (-31.62%↓ Y/Y)Total liabilities andstockholders equity...$11,033,795 (-78.85%↓ Y/Y)Total stockholdersequity (deficit)-$497,307 (-101.14%↓ Y/Y)Additionalpaid-in-capital$209,637,990 (3.11%↑ Y/Y)Common stock, 0.001 parvalue 300,000,000 and...$35,144 (13.41%↑ Y/Y)Total liabilities$11,531,102 (35.91%↑ Y/Y)Total currentliabilities$11,531,102 (38.73%↑ Y/Y)Estimate for accruedlegal contingencies...$5,417,250 (199.95%↑ Y/Y)Accounts payable$4,278,419 (32.77%↑ Y/Y)Other currentliabilities$966,121 (-56.48%↓ Y/Y)Accrued payrollliabilities$690,566 (-20.44%↓ Y/Y)Insurance premium loanpayable$143,050 Operating leaseliability, current portion$35,696 (-81.70%↓ Y/Y)

Skye Bioscience, Inc. (SKYE)

Skye Bioscience, Inc. (SKYE)